CVS announced Tuesday it will expand its use of lower-cost biosimilars and tr | The move to prioritize biosimilars comes as ...

CVS Caremark will expand the use of lower-cost biosimilars across multiple therapeutic categories effective July 1.

May 5 () - CVS Health said on Tuesday it would prefer lower-cost, interchangeable biosimilars ‌over Johnson & Johnson's ...

Retired social worker Nina Nestor got an all-too-familiar phone call last week: Her prescription refill was ready at her CVS store in San Clemente. Trouble is, the 83-year-old cancer patient didn’t ...

CVS Health (NYSE: CVS) today announced updates to its most common commercial template formularies that will expand the use of lower-cost biosimilars across multiple therapeutic categories, including ...